|Purdue University, Ph.D.|
|Grand Valley State University, B.S.|
Dr. Radzik has more than 25 years of experience in the biopharmaceutical industry where she has contributed to the development, approval and commercial technical support of both small and large molecule therapies.
Prior to joining AVEO, Dr. Radzik most recently served as vice president, technical operations at Sanofi Pasteur Biologics (formerly Acambis) where she was responsible for bulk and drug product production of live viral vaccines.
Prior to this role, Dr. Radzik served as senior vice president of U.S. technical operations for UCB, where she was a site director and accountable for the supply chain of numerous products.
Prior to joining UCB by acquisition, she held various senior positions at Celltech and Celltech’s predecessor, Medeva Inc., including head of technical operations and development and global quality assurance.
She has also held leadership roles at Hoechst-Roussel, Marion Merrell Dow and Lederle Laboratories/Medical Research Division of American Cyanamid.
Dr. Radzik received a B.S. in chemistry from Grand Valley State University and a Ph.D. in analytical chemistry from Purdue University.